Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies.
about
Malassezia intra-specific diversity and potentially new species in the skin microbiota from Brazilian healthy subjects and seborrheic dermatitis patients.Treatment of Seborrheic Dermatitis Using a Novel Herbal-based Cream.Hydrocortisone 1% cream and sertaconazole 2% cream to treat facial seborrheic dermatitis: A double-blind, randomized clinical trial.Comprehensive pyrosequencing analysis of the bacterial microbiota of the skin of patients with seborrheic dermatitis.Treatment of Seborrhoeic Dermatitis in Asia: A Consensus GuideEvaluation of a Topical Anti-inflammatory/Antifungal Combination Cream in Mild-to-moderate Facial Seborrheic Dermatitis: An Intra-subject Controlled Trial Examining Treated vs. Untreated Skin Utilizing Clinical Features and Erythema-directed DigitalSeborrheic Dermatitis and Dandruff: A Comprehensive Review.Profile of patients admitted to a triage dermatology clinic at a tertiary hospital in São Paulo, Brazil.Efficacy and Safety of Cream Containing Climbazole/Piroctone Olamine for Facial Seborrheic Dermatitis: A Single-Center, Open-Label Split-Face Clinical Study.Effectiveness of five antidandruff cosmetic formulations against planktonic cells and biofilms of dermatophytes.Skin disorders in Parkinson's disease: potential biomarkers and risk factors.Nanomedicine strategies for targeting skin inflammation.Vulvar dermatoses: a histopathologic review and classification of 183 cases.Psoriatic arthritis and psoriasis: differential diagnosis.Noncorticosteroid Combination Shampoo versus 1% Ketoconazole Shampoo for the Management of Mild-to-Moderate Seborrheic Dermatitis of the Scalp: Results from a Randomized, Investigator-Single-Blind Trial Using Clinical and Trichoscopic Evaluation.Prevalence and determinants of seborrheic dermatitis in a middle aged and elderly population: the Rotterdam Study.[Cutaneous Malassezia infections and Malassezia associated dermatoses: An update].Efficacy of Oral Itraconazole in the Treatment and Relapse Prevention of Moderate to Severe Seborrheic Dermatitis: A Randomized, Placebo-Controlled Trial.Comparison of different regimens of pimecrolimus 1% cream in the treatment of facial seborrheic dermatitis.[Psoriasis capitis and seborrhoic eczema of scalp diseases].Single-center, noninterventional clinical trial to assess the safety, efficacy, and tolerability of a dimeticone-based medical device in facilitating the removal of scales after topical application in patients with psoriasis corporis or psoriasis ca2016 European guideline for the management of vulval conditions.Staphylococcus aureus is the most common bacterial agent of the skin flora of patients with seborrheic dermatitis.JunB defines functional and structural integrity of the epidermo-pilosebaceous unit in the skin
P2860
Q30418132-F9C3D6BF-19B1-425D-B43A-12A9398124ACQ33602427-6EF24CFE-1AC9-46DF-9B9C-BE3D0EBE7F02Q33715147-205C5A92-74B8-438A-9638-E0C91E35A364Q36052273-62106F8A-9A49-4B89-A0EA-C1D64AAE1E91Q36069488-8665C716-A5DC-487D-9E37-D8C9787184A8Q36105225-1ED6F48F-D46D-4436-AC9E-01C8734542ADQ36857323-8153CEE6-470F-4D63-A979-7CBAD3ABE564Q37078902-3CB88270-30FA-49EB-B24A-3C79228FD908Q37446822-7A17638D-38F3-43DD-A7BF-0B12A45F2D9AQ37610861-69B99FD7-3C7C-4DA1-A2B4-AD659782535BQ37702287-6B476311-AE47-4494-9233-77E6CBADBDA9Q38260735-468FE7F2-0557-4574-B155-087343E5F85FQ38495075-E7F671B3-595E-4ECC-86E4-CEC7FC694673Q38828427-3CCDA332-8ABA-4F31-9A0A-D99F983D5033Q39772403-AEA057D6-C8FA-4815-91D6-32A923EE6430Q40063755-B3BD95A4-55EF-44B9-8705-92B6D3D784A3Q41236503-8D82DCA9-A05B-4409-86E6-1A785F3B6850Q48182426-C629D78D-BAF5-4944-9723-75885E1DB831Q48315754-EFFFF5EF-6687-42FB-9669-9B86EA8974E4Q50205933-4D0FEF17-C653-4879-8410-1914440AEDD2Q51756478-1545FB4D-27DB-477D-8688-E76343A515A7Q54439689-9D07DC89-4724-49CE-9FFE-689F67C77D6CQ55090845-B8704AEE-209C-4AFB-AC89-2BAA29E8305FQ58708065-B4B89BD0-2715-46F5-B44D-D2B55F5B41E4
P2860
Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies.
@ast
Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies.
@en
Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies.
@nl
type
label
Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies.
@ast
Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies.
@en
Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies.
@nl
prefLabel
Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies.
@ast
Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies.
@en
Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies.
@nl
P1476
Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies.
@en
P2093
Andreas Katsambas
Clio Dessinioti
P304
P356
10.1016/J.CLINDERMATOL.2013.01.001
P577
2013-07-01T00:00:00Z